Dybbs Michael 4
4 · SUTRO BIOPHARMA, INC. · Filed Jun 10, 2024
Insider Transaction Report
Form 4
Dybbs Michael
Director
Transactions
- Award
Stock Option (right to buy)
2024-06-06+35,000→ 35,000 totalExercise: $3.76Exp: 2034-06-06→ Common Stock (35,000 underlying)
Footnotes (1)
- [F1]The option vests as to 8.33% of the total award monthly, commencing July 6, 2024, with 100% of the award vested and exercisable on the earlier of the date of the issuer's 2025 annual stockholders meeting or June 6, 2025, subject to the reporting person's provision of service to the issuer on each vesting date.